Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704613 · ClinicalTrials.gov registry record
Planning Margin Requirements for Pediatric Radiation Oncology
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 375
- Enrollment target
NCT00704613: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT00704613 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 375 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00704613 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 375 participants
- Enrollment target
Study Summary
The planning target volume (PTV) and planning organ at risk volume (PRV) margins used for pediatric radiation therapy are empiric, and quantitative assessment of these margins is needed to improve therapy planning and delivery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-07 |
What the finished NCT00704613 record still lists
NCT00704613 is an observational study that tracks outcomes without assigning an intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00704613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00704613 about?
NCT00704613 is a clinical study titled "Planning Margin Requirements for Pediatric Radiation Oncology". The planning target volume (PTV) and planning organ at risk volume (PRV) margins used for pediatric radiation therapy are empiric, and quantitative assessment of these margins is needed to improve therapy planning and delivery.
What is the current status of trial NCT00704613?
This trial is currently completed. The enrollment target is 375 participants. The study started on 2008-03. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00704613?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia